NCT04201964View on ClinicalTrials.gov

Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Ischemic Stroke
Interventions
DRUG

Intra-arterial administration of tenecteplase

Intra-arterial administration of tenecteplase (0.2-0.4 mg/min) immediately after thrombectomy device pass for 30-40 minutes.

Trial Locations (1)

110840

RECRUITING

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

Hui-Sheng Chen

OTHER